Rather, we suspected that reduced expression of nuclear TCF7L2 by insulin resistance might be in part responsible for the enhanced hepatic glucose production, providing a potential mechanism for the hyperglycemic phenotype that is induced by DIO or genetic insulin resistance in mammals (Figure 7F). Here, TCF7L2 is linked to Insulin resistance.